A Controlled Trial of Mitoxantrone in Multiple Sclerosis: Serial MRI Evaluation at One Year

Rating neurologic impairment in multiple sclerosis

1983 • 14,011 citations

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

1983 • 7,404 citations

QUANTIFICATION OF CEREBRAL OXYGENATION AND HAEMODYNAMICS IN SICK NEWBORN INFANTS BY NEAR INFRARED SPECTROPHOTOMETRY

1986 • 874 citations

NUCLEAR MAGNETIC RESONANCE IMAGING OF THE BRAIN IN MULTIPLE SCLEROSIS

1981 • 475 citations

Major differences in the dynamics of primary and secondary progressive multiple sclerosis

1991 • 473 citations

SERIAL GADOLINIUM ENHANCED MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS

1988 • 397 citations

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

1991 • 373 citations

Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

1992 • 328 citations

Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history

1991 • 295 citations

Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients

1989 • 251 citations

McAlpine's Multiple Sclerosis

1991 • 211 citations

Heterogeneity of blood‐brain barrier changes in multiple sclerosis

1990 • 201 citations

Nuclear magnetic resonance imaging in multiple sclerosis

1983 • 199 citations

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect.

1992 • 190 citations

Multiple sclerosis

1988 • 186 citations

Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.

1988 • 179 citations

McAlpine's Multiple sclerosis

1985 • 175 citations

THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY

1991 • 172 citations

Cognitive change following MPTP exposure

1990 • 146 citations

Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.

1986 • 125 citations

Serial study of gadolinium‐DTPA MRI enhancement in multiple sclerosis

1990 • 116 citations

Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice.

1986 • 109 citations

Multiple sclerosis disease activity correlates with gadolinium‐enhanced magnetic resonance imaging

1987 • 102 citations

An open‐trial evaluation of mitoxantrone in the treatment of progressive MS

1993 • 86 citations

Regional suppression, therapy after onset and prevention of relapses in experimental allergic encephalomyelitis by mitoxantrone

1986 • 56 citations

Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis

1988 • 56 citations

Magnetic Resonance Imaging Lesion Enlargement in Multiple Sclerosis

1992 • 48 citations

Neuroepidemiology. Part II: Assessment of therapeutic trials

1986 • 26 citations

The dynamics of multiple sclerosis

1993 • 20 citations

Assessing the Outcome of Experimental Therapies in Multiple Sclerosis Patients

1992 • 9 citations